/GL
GL Stock - Globe Life Inc.
Financial Services|Insurance - LifeNYSE
$139.64+0.80%
+$1.11 (+0.80%) • Dec 19
79
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.66
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).93
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+21.7%upside
Target: $169.94
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$138.24 – $141.04
TARGET (TP)$170.00
STOP LOSS$128.47
RISK/REWARD1:2.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.48
52W High$147.83
52W Low$107.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.78B | $5.45B | $5.23B | $5.12B | $4.74B |
| Gross Profit | $1.87B | $1.64B | $1.54B | $1.69B | $1.28B |
| Gross Margin | 32.4% | 30.1% | 29.5% | 32.9% | 27.1% |
| Operating Income | $1.33B | $1.19B | $1.10B | $1.27B | $896.68M |
| Net Income | $1.07B | $970.75M | $894.39M | $1.03B | $731.77M |
| Net Margin | 18.5% | 17.8% | 17.1% | 20.1% | 15.4% |
| EPS | $11.99 | $10.21 | $7.55 | $7.30 | $6.90 |
Company Overview
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Visit WebsiteRating Distribution
Strong Buy
1
13%
Buy / Outperform
5
63%
Hold / Neutral
2
25%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
6 Bullish2 Neutral/Bearish
Price Targets
$132
Average Target
↓ 5.4% Downside
Now
$110
Low
$132
Average
$166
High
Based on 12 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 5th 2025 | Morgan Stanley | Upgrade | Overweight | $166 |
| July 15th 2025 | Truist | Initiation | Buy | $150 |
| January 23rd 2025 | BMO Capital Markets | Initiation | Market Perform | $114 |
| January 8th 2025 | Evercore ISI | Upgrade | Outperform | $143← $132 |
| October 9th 2024 | TD Cowen | Initiation | Buy | $150 |
| April 24th 2024 | Keefe Bruyette | Upgrade | Outperform | $110← $130 |
| October 31st 2023 | Wells Fargo | Upgrade | Overweight | $137← $122 |
| August 18th 2023 | Morgan Stanley | Upgrade | Equal Weight | $131 |
| April 25th 2023 | Wells Fargo | Initiation | Equal Weight | $120 |
| October 28th 2022 | Evercore ISI | Downgrade | In-line | $114← $115 |
| September 22nd 2022 | Raymond James | Initiation | Strong Buy | $138 |
| June 15th 2022 | Evercore ISI | Upgrade | Outperform | $112← $105 |
Earnings History & Surprises
GLBeat Rate
72%
Last 18 quarters
Avg Surprise
+1.4%
EPS vs Estimate
Beats / Misses
13/5
Last 12 quarters
Latest EPS
$4.81
Q4 2025
EPS Surprise History
Q1 24
+2.6%
$2.80vs$2.73
Q2 24
-0.4%
$2.78vs$2.79
Q3 24
+2.1%
$2.97vs$2.91
Q4 24
+14.1%
$3.49vs$3.06
Q1 25
+0.6%
$3.14vs$3.12
Q2 25
-5.0%
$3.07vs$3.23
Q3 25
+0.6%
$3.27vs$3.25
Q4 25
+5.9%
$4.81vs$4.54
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $3.44 | — | — | — |
Q4 2025 | Oct 22, 2025 | $4.54 | $4.81 | +5.9% | ✓ BEAT |
Q3 2025 | Jul 23, 2025 | $3.25 | $3.27 | +0.6% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $3.23 | $3.07 | -5.0% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $3.12 | $3.14 | +0.6% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $3.06 | $3.49 | +14.1% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $2.91 | $2.97 | +2.1% | ✓ BEAT |
Q2 2024 | Apr 22, 2024 | $2.79 | $2.78 | -0.4% | ✗ MISS |
Q1 2024 | Feb 7, 2024 | $2.73 | $2.80 | +2.6% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $2.65 | $2.71 | +2.3% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $2.57 | $2.61 | +1.6% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $2.47 | $2.53 | +2.4% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $2.17 | $2.24 | +3.2% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $2.10 | $2.15 | +2.4% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $2.05 | $2.07 | +1.0% | ✓ BEAT |
Q2 2022 | Apr 20, 2022 | $1.72 | $1.70 | -1.2% | ✗ MISS |
Q1 2022 | Feb 2, 2022 | $1.76 | $1.70 | -3.4% | ✗ MISS |
Q4 2021 | Oct 20, 2021 | $1.89 | $1.78 | -5.8% | ✗ MISS |
Q3 2021 | Jul 21, 2021 | $1.82 | $1.85 | +1.6% | ✓ BEAT |
Latest News
TD Cowen Maintains Buy on Globe Life, Raises Price Target to $199
📈 PositiveBenzinga•Dec 11, 2025, 04:55 PM
Morgan Stanley Maintains Overweight on Globe Life, Lowers Price Target to $177
➖ NeutralBenzinga•Nov 17, 2025, 02:47 PM
Keefe, Bruyette & Woods Maintains Outperform on Globe Life, Raises Price Target to $162
📈 PositiveBenzinga•Oct 28, 2025, 01:14 PM
Truist Securities Maintains Buy on Globe Life, Raises Price Target to $158
📈 PositiveBenzinga•Oct 24, 2025, 06:05 PM
Wells Fargo Maintains Overweight on Globe Life, Lowers Price Target to $170
➖ NeutralBenzinga•Oct 24, 2025, 02:01 PM•Also:
Globe Life Sees FY2026 Adj EPS $14.60-$15.30 vs $15.01 Est
➖ NeutralBenzinga•Oct 22, 2025, 08:12 PM
Globe Life Narrows FY2025 Adj EPS Guidance from $14.25-$14.65 to $14.40-$14.60 vs $14.40 Est
➖ NeutralBenzinga•Oct 22, 2025, 08:12 PM
Globe Life Q3 Adj. EPS $4.81 Beats $4.54 Estimate, Sales $1.513B Miss $1.519B Estimate
📈 PositiveBenzinga•Oct 22, 2025, 08:10 PM
Wells Fargo Maintains Overweight on Globe Life, Raises Price Target to $172
📈 PositiveBenzinga•Oct 8, 2025, 02:15 PM
Morgan Stanley Maintains Overweight on Globe Life, Raises Price Target to $171
📈 PositiveBenzinga•Aug 18, 2025, 01:22 PM
Frequently Asked Questions about GL
What is GL's current stock price?
Globe Life Inc. (GL) is currently trading at $139.64 per share. The stock has moved +0.80% today.
What is the analyst price target for GL?
The average analyst price target for GL is $170.00, based on 1 analyst.
What sector is Globe Life Inc. in?
Globe Life Inc. operates in the Financial Services sector, specifically within the Insurance - Life industry. The company is traded on the NYSE exchange.
What is GL's market cap?
Globe Life Inc. has a market capitalization of $11.12 billion, making it a large-cap company.
Does GL pay dividends?
No, Globe Life Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAEG
Aegon Ltd.
$7.54
Mkt Cap: $12.0B
AFG
American Financial Group, Inc.
$137.46
Mkt Cap: $11.5B
AIZ
Assurant, Inc.
$239.02
Mkt Cap: $12.0B
GGAL
Grupo Financiero Galicia S.A.
$54.17
Mkt Cap: $8.7B
LNC
Lincoln National Corporation
$46.21
Mkt Cap: $8.8B
MET
MetLife, Inc.
$81.57
Mkt Cap: $53.7B
ORI
Old Republic International Corporation
$45.51
Mkt Cap: $11.3B
PRI
Primerica, Inc.
$258.83
Mkt Cap: $8.3B
UNM
Unum Group
$79.24
Mkt Cap: $13.3B
Explore stocks similar to GL for comparison